These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 988964)

  • 1. Human pharmacokinetics of sotalol.
    Anttila M; Arstila M; Pfeffer M; Tikkanen R; Vallinkoski V; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):118-28. PubMed ID: 988964
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of the -adrenergic blocker sotalol in dogs.
    Schnelle K; Garrett ER
    J Pharm Sci; 1973 Mar; 62(3):362-75. PubMed ID: 4144183
    [No Abstract]   [Full Text] [Related]  

  • 3. The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.
    Poirier JM; Jaillon P; Lecocq B; Lecocq V; Ferry A; Cheymol G
    Eur J Clin Pharmacol; 1990; 38(6):579-82. PubMed ID: 2373132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observations on the efficacy and pharmacokinetics of sotalol after oral administration.
    Brown HC; Carruthers SG; Kelly JG; McDevitt DG; Shanks RG
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):367-72. PubMed ID: 971701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of oral charcoal and urine pH on sotalol pharmacokinetics.
    Kärkkäinen S; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):441-6. PubMed ID: 6092287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of sotalol during pregnancy.
    O'Hare MF; Leahey W; Murnaghan GA; McDevitt DG
    Eur J Clin Pharmacol; 1983; 24(4):521-4. PubMed ID: 6861867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics in young normal and elderly hypertensive subjects: a study using sotalol as a model drug.
    Ishizaki T; Hirayama H; Tawara K; Nakaya H; Sato M; Sato K
    J Pharmacol Exp Ther; 1980 Jan; 212(1):173-81. PubMed ID: 6101341
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacokinetics of a fixed combination of sotalol and hydrochlorothiazide in hypertensive patients with moderate renal insufficiency.
    Kher A; Fillastre JP; Fourtillan JB; Lefebvre MA; Ingrand I
    Eur J Clin Pharmacol; 1984; 27(3):361-2. PubMed ID: 6510465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of once daily sotalol administration in man.
    McDewitt DG; Shanks RG
    Br J Clin Pharmacol; 1977 Apr; 4(2):153-6. PubMed ID: 861130
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorption kinetics of oral sotalol combined with cisapride and sublingual sotalol in healthy subjects.
    Deneer VH; Lie-A-Huen L; Kingma JH; Proost JH; Kelder JC; Brouwers JR
    Br J Clin Pharmacol; 1998 May; 45(5):485-90. PubMed ID: 9643622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels and half-life of sotalol in chronic renal failure.
    Sundquist HK; Anttila M; Forsström J; Kasanen A
    Ann Clin Res; 1975 Dec; 7(6):442-6. PubMed ID: 1211858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative pharmacokinetic and pharmacodynamic properties of oral and intravenous (+)-sotalol in healthy volunteers.
    Uematsu T; Kanamaru M; Nakashima M
    J Pharm Pharmacol; 1994 Jul; 46(7):600-5. PubMed ID: 7996391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of food, food constituents and fluid volume on the bioavailability of sotalol.
    Kahela P; Anttila M; Tikkanen R; Sundquist H
    Acta Pharmacol Toxicol (Copenh); 1979 Jan; 44(1):7-12. PubMed ID: 367055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of arterial hypertension with sotalol, a beta-blocker (author's transl)].
    Klein G; Schnelle K; Schinz A; Oberländer V
    Dtsch Med Wochenschr; 1977 Apr; 102(15):563-9. PubMed ID: 849711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
    Aro A; Anttila M; Korhonen T; Sundquist H
    Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive effects of practolol and sotalol.
    Sundquist H; Anttila M; Arstila M
    Clin Pharmacol Ther; 1974 Sep; 16(3):465-72. PubMed ID: 4606232
    [No Abstract]   [Full Text] [Related]  

  • 17. [Plasma level and action of sotalol-HCL on the ECG interval after parenteral administration in healthy subjects].
    Rehm KD; Schnelle K; Dyde CJ; Blümner E; Arendts W
    Arzneimittelforschung; 1987 Sep; 37(9):1058-62. PubMed ID: 3435602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative bioavailability and pharmacokinetics of sotalol administered alone and in combination with hydrochlorothiazide.
    Sundquist H; Anttila M; Simon A; Reich JW
    J Clin Pharmacol; 1979; 19(8-9 Pt 2):557-64. PubMed ID: 489773
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma clearance of propranolol and sotalol and hepatic drug-metabolizing enzyme activity.
    Sotaniemi EA; Anttila M; Pelkonen RO; Järvensivu P; Sundquist H
    Clin Pharmacol Ther; 1979 Aug; 26(2):153-61. PubMed ID: 455885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic study of sotalol after 320 mg single oral doses in healthy adults using high performance liquid chromatography (author's transl)].
    Fourtillan JB; Lefebvre MA; Courtois P; Saux MC
    Therapie; 1981; 36(4):457-63. PubMed ID: 7292429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.